S
Seaside Therapeutics
Drug treatments for neurodevelopmental disorders, including Fragile X syndrome and autism
About Seaside Therapeutics
Seaside Therapeutics was a biopharmaceutical company that focused on the development of therapeutics for neurodevelopmental disorders.
The company's primary objective was to create treatments for conditions such as Fragile X syndrome and autism spectrum disorders by targeting the underlying neurobiology of these conditions. Seaside Therapeutics aimed to translate scientific discoveries into clinical applications, with a specific focus on the mGluR5 and GABA-B pathways, which are believed to play a role in the synaptic dysfunction associated with these disorders.
The company is no longer in business.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2005
- Headquarters
- Cambridge, United States
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 58.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Sep 2009 | $30M | $120M | Undisclosed | — |
| SPINOUT✓Other financing | Sep 2005 | $0 | — | Massachusetts Institute of Technology | — |
Growth signals
Latest recorded traffic for Seaside Therapeutics is 170 monthly website visits. Seaside Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Seaside Therapeutics in the Cambridge ecosystem
The Seaside Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Massachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Seaside Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Seaside Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









